EDAR Antikörper (Extracellular Domain)
Kurzübersicht für EDAR Antikörper (Extracellular Domain) (ABIN360882)
Target
Alle EDAR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- Extracellular Domain
-
Spezifität
- This antibody detects EDAR and cross reacts with human EDAR.
-
Aufreinigung
- Protein A/G affinity chromatography
-
Immunogen
- Recombinant extracellular domain of EDAR
-
Isotyp
- IgG2
-
-
-
-
Applikationshinweise
-
Western Blot: 1/500 - 1/1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Restore with 200 μL sterile PBS and the final concentration is 500 μg/mL.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Prior to reconstitution store at 2-8 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- EDAR (Ectodysplasin A Receptor (EDAR))
-
Andere Bezeichnung
- EDAR
-
Hintergrund
- EDAR (Ectodysplasin A receptor) is a receptor for EDA isoform A1, but not for EDA isoform A2. It has a single transmembrane domain, and shows similarity to 2 separate domains of the tumor necrosis factor (TNF) receptor (TNFR) family. It mediates the activation of NF-kappa-B and JNK and may promote caspase independent cell death. Defects in EDAR are a cause of hypohidrotic ectodermal dysplasia.Synonyms: Anhidrotic ectodysplasin receptor 1, DL, Downless homolog, ED1R, ED3, ED5, EDA-A1 receptor, EDA-A1R, EDA1R, EDA3, Ectodermal dysplasia receptor, Ectodysplasin-A receptor, FLJ94390, HRM1, Tumor necrosis factor receptor superfamily member EDAR
-
Gen-ID
- 13608
-
NCBI Accession
- NP_034230
-
UniProt
- Q9R187
-
Pathways
- Tube Formation, Ubiquitin Proteasome Pathway
Target
-